The current pandemic which the world has been experiencing for the last 6 months now, has made some of the major changes in the priorities that the world sees today as important and critical. We have already witnessed some of these changes and steps taken by the world economies in combating and trying to minimize the adverse impact. We all hope that the recovery would be V-shaped instead of an L-shaped one.
In the area of vaccines, it is heartening to note that worldwide we have more than 120 vaccine candidates that are being worked upon at breakneck speed and at least five of these are from notable Indian Pharma companies and to top it all it is worth mentioning that over 70% of the vaccines that are manufactured in the world are made in India. Yes, of course, the Indian companies will have a very responsible task on hand when the vaccine candidate is finally cleared for human consumption as once again the manufacturing sites in India like the Serum Institute, Bharat Biotech, Zydus Cadila, Biological Evans amongst others would be the centre stage of the vaccine manufacturing activity.
I am sure the role of AI, IOT, and Robotics would find tremendous application in the Pharma sector, as we all know that any new chemical entity which is cleared for commercial human use would have initially started with approximately 10000 compounds for possible final drug product hitting the market. Therefore, one can well imagine the important role of AI that will be put to use in molecule identification and the iterations thereof, disease understanding, disruptive product design leading to optimum products and solutions with design thinking and generative approaches that will be a whole new extensive area to be addressed in next article.